CoV-2 RT PCR |
|
|
|
A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase. C169076:C18136 |
SARS-Cov-2 RNA level Quantitative |
|
|
|
The determination of the amount of SARS-CoV-2 RNA in a sample. C171531 |
SARS-CoV-2 RNA detection Qualitative |
|
|
|
Any antibody that recognizes the severe acute respiratory syndrome 2 virus.:A type of evaluation that is primarily descriptive and interpretative, and may or may not lend itself to quantification. Mainly concerned with the properties, the state, and the character (i.e., the nature) of phenomena. It implies an emphasis on processes and meanings that are rigorously examined, but not measured in terms of quantity, amount, or frequency. (www.unfpa.org/monitoring/toolkit/glossary.pdf and Nonprofit Good Practice Guide Glossary) C173464:C49143 |
SARS-CoV-2 viral load |
|
|
|
A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:A measurement of the total number of viral particles of a pre-specified virus in a specimen. C169076:C174331 |
SARS-COV-2 Rapid Antigen |
|
|
|
A positive-sense single-stranded RNA virus in the genus Betacoronavirus. It is the causative agent of the 2019-2020 severe acute respiratory syndrome outbreak.:An immunoassay that can quickly detect the presence of specific antigens in a sample and return results during a patient visit. C169076:C53465 |
SARS CoV-2 IgM (Antibody) |
|
|
|
The protein on surface of target cells specific for binding IGF. There are two types of IGF receptor, one of which closely resembles the insulin receptor. C17530 |
IgG or Neutralizing Antibody/Serologic |
|
|
|
The determination of the amount of SARS-CoV-2 IgG antibody in a sample.:An article used to connect words, phrases, or clauses representing alternatives; used to connect alternative terms for the same thing; used in correlation; used to correct or rephrase what was previously said; otherwise.:The determination of the amount of SARS-CoV-2 neutralizing antibody in a biological sample. C171528:C37998:C174329 |
SARS CoV-2 Antigen |
|
|
|
The determination of the amount of SARS-CoV-2 antigen in a biological sample. C176327 |
Serum cytokine |
|
|
|
The clear portion of the blood that remains after the removal of the blood cells and the clotting proteins.:A class of soluble glycoproteins which act nonenzymatically through specific receptors to regulate immune responses. Cytokines are derived from both immune and non-immune cells and are intercellular mediators that differ from hormones in that they are produced by a number of tissue or cell types rather than by specialized glands.:Annotation used to indicate the size or magnitude of something that was determined by comparison to a standard. C13325:C20464:C25209 |
Other, Specify |
|
|
|
A directive to specify when the listed responses are not sufficient. C157101 |